Patient-Friendly Explanation

AOD-9604 is an experimental peptide based on a fragment of human growth hormone that was investigated as a possible fat-burning treatment. Early animal studies suggested it could reduce body fat, but human trials did not show meaningful weight loss, and it has not been approved by regulators. It is sometimes sold online unregulated, which carries safety risks.

Clinical Definition

AOD-9604 is a modified peptide fragment (amino acids 177-191) of human growth hormone, developed to mimic the lipolytic effects of growth hormone without its anabolic or glycaemic side effects. Preclinical studies showed modest anti-obesity activity, but randomised human trials failed to demonstrate clinically significant weight loss, and development for obesity was discontinued. It is not approved for weight management by any major regulatory body.

Why It Matters

It is important to rely on proven, regulated treatments rather than experimental compounds sold online. At NuLifeCare Singapore we use only evidence-based, medically supervised options for weight management so your safety and results come first.